• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿立哌唑用于酒精使用障碍的预防复发和抑制渴求:当前证据与未来展望。

Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives.

作者信息

Martinotti Giovanni, Orsolini Laura, Fornaro Michele, Vecchiotti Roberta, De Berardis Domenico, Iasevoli Felice, Torrens Marta, Di Giannantonio Massimo

机构信息

a Department of Neuroscience, Imaging and Clinical Science , University of 'G. D'Annunzio' , Chieti , Italy.

b School of Life and Medical Sciences , University of Hertfordshire , Herts , UK.

出版信息

Expert Opin Investig Drugs. 2016 Jun;25(6):719-28. doi: 10.1080/13543784.2016.1175431. Epub 2016 Apr 21.

DOI:10.1080/13543784.2016.1175431
PMID:27098451
Abstract

INTRODUCTION

Among other approaches, the modulation of the dopaminergic pathway has been advocated in the therapeutic management of Alcohol Use Disorders (AUD). A potential avenue toward the modulation of the dopaminergic pathway across varying substance disorders seems to be provided by aripiprazole, a second-generation antipsychotic characterized by a peculiar pharmacodynamics signature.

AREAS COVERED

In this review, the authors provided a qualitative synthesis and a critical perspective on the efficacy of aripiprazole in relapse prevention and craving in AUD. A systematic search was carried out through MEDLINE/Embase/PsycINFO/Cochrane Library from inception until September 2015, combining free terms and MESH headings for the topics of AUD and aripiprazole as following: (((Alcohol use Disorder) OR (Alcohol use)) AND aripiprazole).

EXPERT OPINION

Based both on a qualitative synthesis and a critical interpretation of the evidence, the authors submit that aripiprazole would promote alcohol abstinence and reduce the alcohol seeking behaviour possibly via dopaminergic and serotoninergic modulations at the fronto-subcortical circuits underpinning alcohol reward and craving, impulsive behaviour as well as reduce alcohol-related anxiety/low mood and anhedonia. However, due to the lack of published studies, a conclusive statement about any direct effect of aripiprazole in the prevention of craving and/or alcohol consumption is not possible.

摘要

引言

在诸多治疗方法中,多巴胺能通路的调节已被提倡用于酒精使用障碍(AUD)的治疗管理。阿立哌唑似乎为跨不同物质使用障碍调节多巴胺能通路提供了一条潜在途径,它是一种具有独特药效学特征的第二代抗精神病药物。

涵盖领域

在本综述中,作者对阿立哌唑在预防AUD复发及减少渴求方面的疗效进行了定性综合分析并给出批判性观点。从创刊至2015年9月,通过MEDLINE/Embase/PsycINFO/考克兰图书馆进行了系统检索,将AUD和阿立哌唑主题的自由词与医学主题词相结合,检索式如下:(((酒精使用障碍) 或 (酒精使用)) 且 阿立哌唑)。

专家意见

基于定性综合分析及对证据的批判性解读,作者认为阿立哌唑可能通过对支持酒精奖赏、渴求、冲动行为的额-皮质下环路进行多巴胺能和5-羟色胺能调节,促进戒酒并减少觅酒行为,同时还能减轻与酒精相关的焦虑/情绪低落及快感缺失。然而,由于缺乏已发表的研究,关于阿立哌唑在预防渴求及/或减少酒精消费方面的任何直接作用,都无法得出结论性陈述。

相似文献

1
Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives.阿立哌唑用于酒精使用障碍的预防复发和抑制渴求:当前证据与未来展望。
Expert Opin Investig Drugs. 2016 Jun;25(6):719-28. doi: 10.1080/13543784.2016.1175431. Epub 2016 Apr 21.
2
Aripiprazole Suppression of Drinking in a Clinical Laboratory Paradigm: Influence of Impulsivity and Self-Control.阿立哌唑对临床实验室范式中饮酒的抑制作用:冲动性和自我控制的影响。
Alcohol Clin Exp Res. 2017 Jul;41(7):1370-1380. doi: 10.1111/acer.13417. Epub 2017 Jun 5.
3
Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence.阿立哌唑:一种具有全新作用机制的药物,可能对酒精依赖有效。
CNS Neurol Disord Drug Targets. 2010 Mar;9(1):50-4. doi: 10.2174/187152710790966731.
4
Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control.阿立哌唑对临床实验室范式中酒精消费及主观报告的影响——自我控制的可能作用
Alcohol Clin Exp Res. 2008 Nov;32(11):1954-61. doi: 10.1111/j.1530-0277.2008.00783.x. Epub 2008 Sep 8.
5
Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone.阿立哌唑治疗酒精依赖患者:与纳曲酮的双盲对照试验
J Psychopharmacol. 2009 Mar;23(2):123-9. doi: 10.1177/0269881108089596. Epub 2008 May 30.
6
Aripiprazole for cocaine abstinence: a randomized-controlled trial with ecological momentary assessment.阿立哌唑用于可卡因戒断:一项采用生态瞬时评估的随机对照试验。
Behav Pharmacol. 2017 Feb;28(1):63-73. doi: 10.1097/FBP.0000000000000268.
7
Randomized open-label trial of baclofen for relapse prevention in alcohol dependence.巴氯芬预防酒精依赖复发的随机开放标签试验。
Am J Drug Alcohol Abuse. 2017 May;43(3):324-331. doi: 10.1080/00952990.2016.1240797. Epub 2016 Nov 3.
8
Concurrent, successful management of bipolar I disorder with comorbid alcohol dependence via aripiprazole long-acting injection: A case report.阿立哌唑长效注射剂联合成功治疗伴有酒精依赖共病的双相I型障碍:一例报告
Neuropsychopharmacol Rep. 2019 Sep;39(3):238-240. doi: 10.1002/npr2.12072. Epub 2019 Jul 20.
9
Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study.在一项人体实验室研究中比较和联合使用托吡酯与阿立哌唑对酒精相关结果的影响
Alcohol Alcohol. 2018 May 1;53(3):268-276. doi: 10.1093/alcalc/agx108.
10
Reward and relief craving tendencies in patients with alcohol use disorders: results from the PREDICT study.奖励和缓解酒精使用障碍患者的渴求倾向:PREDICT 研究结果。
Addict Behav. 2013 Feb;38(2):1532-1540. doi: 10.1016/j.addbeh.2012.06.018. Epub 2012 Jun 26.

引用本文的文献

1
Partial Dopamine D2/3 Agonists and Dual Disorders: A Retrospective-Cohort Study in a Real-World Clinical Setting on Patients with Schizophrenia Spectrum Disorders and Cannabis Use Disorder.部分多巴胺D2/3激动剂与双重障碍:一项针对精神分裂症谱系障碍和大麻使用障碍患者的真实临床环境中的回顾性队列研究。
Curr Neuropharmacol. 2025;23(8):996-1006. doi: 10.2174/011570159X350599241214042724.
2
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System.揭示药物诱导冲动性的负担:FDA 不良事件报告系统的网络分析。
Drug Saf. 2024 Dec;47(12):1275-1292. doi: 10.1007/s40264-024-01471-z. Epub 2024 Aug 15.
3
"It's been a long time since I drank like that": A case report of binge drinking associated with aripiprazole.
“我已经很久没有那样酗酒了”:一例与阿立哌唑相关的暴饮病例报告
Ment Health Clin. 2024 Jun 3;14(3):212-214. doi: 10.9740/mhc.2024.06.212. eCollection 2024 Jun.
4
[Anxiety and substance abuse disorders-Focus on alcohol and cannabis].[焦虑症与物质使用障碍——聚焦于酒精和大麻]
Nervenarzt. 2023 Jul;94(7):647-654. doi: 10.1007/s00115-023-01502-7. Epub 2023 Jun 21.
5
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics.双相障碍急性发作和慢性管理的药理学策略,重点关注锂、丙戊酸和非典型抗精神病药。
Curr Neuropharmacol. 2023;21(4):935-950. doi: 10.2174/1570159X21666230224102318.
6
Third-generation antipsychotics in patients with schizophrenia and non-responsivity or intolerance to clozapine regimen: What is the evidence?精神分裂症患者中对氯氮平治疗方案无反应或不耐受时使用第三代抗精神病药物:证据是什么?
Front Psychiatry. 2022 Nov 29;13:1069432. doi: 10.3389/fpsyt.2022.1069432. eCollection 2022.
7
Learning processes in relapse to alcohol use: lessons from animal models.复饮过程中的学习机制:动物模型的启示。
Psychopharmacology (Berl). 2023 Mar;240(3):393-416. doi: 10.1007/s00213-022-06254-x. Epub 2022 Oct 20.
8
Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.用于治疗酒精使用障碍的非适应证用药和研究性药物:一项批判性综述
Front Pharmacol. 2022 Oct 3;13:927703. doi: 10.3389/fphar.2022.927703. eCollection 2022.
9
Use and perceived usefulness of a just-in-time resonance breathing intervention adjunct for substance use disorder: Contextual and physiological predictors.即时共振呼吸干预辅助工具在物质使用障碍中的应用及感知有用性:情境和生理预测因素。
Front Psychiatry. 2022 Sep 7;13:945751. doi: 10.3389/fpsyt.2022.945751. eCollection 2022.
10
Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?多巴胺受体部分激动剂:它们的临床疗效有差异吗?
Front Psychiatry. 2022 Jan 25;12:781946. doi: 10.3389/fpsyt.2021.781946. eCollection 2021.